KRAS and colorectal carcinoma: The widely recognized oncogene, KRAS, has the maximum mutation rate and correlates with various kinds of cancers that are extremely fatal, such as pancreatic ductal adenocarcinoma (PDAC, 98%), colorectal cancer (CRC, 52%) and lung adenocarcinoma (LAC, 32%) [6].